{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:35:12Z","timestamp":1787499312022,"version":"build-2736575974"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"DOI":"10.1186\/s12936-025-05320-x","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T13:24:26Z","timestamp":1741785866000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Through the eyes of the participant: using photovoice to understand the experiences and effects of ivermectin MDA in the context of the BOHEMIA clinical trial in Kwale, Kenya"],"prefix":"10.1186","volume":"24","author":[{"given":"Truphena","family":"Onyango","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadija","family":"Nuru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karisa","family":"Kazungu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winnie","family":"Wangari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Chaccour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Regina Rabinovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Mwangangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Maia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,12]]},"reference":[{"key":"5320_CR1","unstructured":"WHO. World malaria report 2023. Geneva, World Health Organization, 2023. Available at https:\/\/www.who.int\/teams\/global-malaria-programme\/reports\/world-malaria-report-2023"},{"key":"5320_CR2","volume-title":"Guidelines for malaria vector control","author":"WHO","year":"2019","unstructured":"WHO. Guidelines for malaria vector control. Geneva: World Health Organization; 2019."},{"key":"5320_CR3","unstructured":"WHO. Guidelines for malaria. Geneva, World Health Organization, 2022. http:\/\/apps.who.int\/bookorders."},{"key":"5320_CR4","volume-title":"Handbook for guideline development","author":"WHO","year":"2012","unstructured":"WHO. Handbook for guideline development. Geneva: World Health Organization; 2012."},{"key":"5320_CR5","first-page":"663","volume":"39","author":"M Kabisch","year":"2011","unstructured":"Kabisch M, Ruckes C, Seibert-Grafe M, Blettner M. Randomized controlled trials: part 17 of a series on evaluation of scientific publications. Dtsch Arztebl Int. 2011;39:663\u20138.","journal-title":"Dtsch Arztebl Int"},{"key":"5320_CR6","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1111\/1471-0528.15199","volume":"125","author":"E Hariton","year":"2018","unstructured":"Hariton E, Locascio JJ. Randomised controlled trials - the gold standard for effectiveness research: Study design: randomised controlled trials. BJOG. 2018;125:1716.","journal-title":"BJOG"},{"key":"5320_CR7","unstructured":"WHO. ExpandNet: Beginning with the end in mind. Planning pilot projects and other programmatic research for successful scaling-up. Geneva, World Health Organization, 2011."},{"key":"5320_CR8","volume-title":"ExpandNet: nine steps for developing a scaling-up strategy","author":"WHO","year":"2010","unstructured":"WHO. ExpandNet: nine steps for developing a scaling-up strategy. Geneva: World Health Organization; 2010."},{"key":"5320_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/15265161.2016.1170230","volume":"16","author":"A Denburg","year":"2016","unstructured":"Denburg A, Rodriguez-Galindo C, Joffe S. Clinical trials infrastructure as a quality improvement intervention in low- and middle-income countries. Am J Bioeth. 2016;16:3\u201311.","journal-title":"Am J Bioeth"},{"key":"5320_CR10","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1080\/15265161.2016.1170242","volume":"16","author":"KP Asante","year":"2016","unstructured":"Asante KP, Jones C, Sirima SB, Molyneux S. Clinical trials cannot substitute for health system strengthening initiatives or specifically designed health policy and systems research. Am J Bioeth. 2016;16:24\u20136.","journal-title":"Am J Bioeth"},{"key":"5320_CR11","volume":"10","author":"V Angwenyi","year":"2015","unstructured":"Angwenyi V, Asante KP, Traor\u00e9 A, Gyabaa Febir L, Tawiah C, Kwarteng A, et al. Health providers\u2019 perceptions of clinical trials: lessons from Ghana. Kenya and Burkina Faso PLoS One. 2015;10: e0124554.","journal-title":"Kenya and Burkina Faso PLoS One"},{"key":"5320_CR12","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/1475-2875-12-157","volume":"12","author":"EA Liheluka","year":"2013","unstructured":"Liheluka EA, Lusingu JP, Manongi RN. Community perceptions on the secondary health benefits established by malaria vaccine trials (RTS, S phase 2 and phase 3) at the Korogwe site in Northeastern Tanzania. Malar J. 2013;12:157.","journal-title":"Malar J"},{"key":"5320_CR13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12936-017-2164-6","volume":"17","author":"C Jones","year":"2018","unstructured":"Jones C, Talisuna AO, Snow RW, Zurovac D. \u201cWe were being treated like the Queen\u201d: understanding trial factors influencing high paediatric malaria treatment adherence in western Kenya. Malar J. 2018;17:8.","journal-title":"Malar J"},{"key":"5320_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12936-017-2158-4","volume":"17","author":"B Adhikari","year":"2018","unstructured":"Adhikari B, Phommasone K, Kommarasy P, Soundala X, Souvanthong P, Pongvongsa T, et al. Why do people participate in mass anti-malarial administration? Findings from a qualitative study in Nong District, Savan-nakhet Province, Lao PDR (Laos). Malar J. 2018;17:15.","journal-title":"Malar J"},{"key":"5320_CR15","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12936-021-03732-z","volume":"20","author":"A Fehr","year":"2021","unstructured":"Fehr A, Nieto-Sanchez C, Muela J, Jaiteh F, Ceesay O, Maneh E, et al. From informed consent to adherence: factors influencing involvement in mass drug administration with ivermectin for malaria elimination in The Gambia. Malar J. 2021;20:198.","journal-title":"Malar J"},{"issue":"Suppl 2","key":"5320_CR16","doi-asserted-by":"publisher","first-page":"28","DOI":"10.4269\/ajtmh.19-0663","volume":"103","author":"K Silumbe","year":"2020","unstructured":"Silumbe K, Finn TP, Jennings T, Sikombe C, Chiyende E, Hamainza B, et al. Assessment of the acceptability of testing and treatment during a mass drug administration trial for malaria in Zambia using mixed methods. Am J Trop Med Hyg. 2020;103(Suppl 2):28\u201336.","journal-title":"Am J Trop Med Hyg"},{"key":"5320_CR17","doi-asserted-by":"crossref","unstructured":"Saita S, Roobsoong W, Khammaneechan P,\u00a0Sukchan P, Lawpoolsri, Cui L, et al.\u00a0Community acceptability, participation, and adherence to mass drug administration with primaquine for\u00a0Plasmodium vivax\u00a0elimination in Southern Thailand: a mixed methods approach.\u00a0Malar J. 2023;22:17.","DOI":"10.1186\/s12936-023-04443-3"},{"key":"5320_CR18","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1093\/trstmh\/try053","volume":"112","author":"TJ Peto","year":"2018","unstructured":"Peto TJ, Tripura R, Sanann N, Adhikari B, Callery J, Droogleever M, et al. The feasibility and acceptability of mass drug administration for malaria in Cambodia: a mixed-methods study. Trans R Soc Trop Med Hyg. 2018;112:264\u201371.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"5320_CR19","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1186\/s12936-016-1528-7","volume":"15","author":"L Kajeechiwa","year":"2016","unstructured":"Kajeechiwa L, Thwin MM, Shee PW, Yee NL, Elvina E, Peapah P, et al. The acceptability of mass administrations of anti-malarial drugs as part of targeted malaria elimination in villages along the Thai Myanmar border. Malar J. 2016;15:494.","journal-title":"Malar J"},{"key":"5320_CR20","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1186\/s12936-022-04321-4","volume":"21","author":"C Jones","year":"2022","unstructured":"Jones C, Matta A, Pinder M, D\u2019Alessandro U, Knudsen J, Lindsay SW. House screening for malaria control: views and experiences of participants in the RooPfs trial. Malar J. 2022;21:294.","journal-title":"Malar J"},{"key":"5320_CR21","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1503\/cmaj.210963","volume":"193","author":"CIJ Nykiforuk","year":"2021","unstructured":"Nykiforuk CIJ. Engaging patients in research using photovoice methodology. Canad Med Assoc. 2021;193:1050\u20131.","journal-title":"Canad Med Assoc"},{"key":"5320_CR22","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1186\/s12936-017-2056-9","volume":"16","author":"C Makungu","year":"2017","unstructured":"Makungu C, Stephen S, Kumburu S, Govella NJ, Dongus S, Hildon ZJL, et al. Informing new or improved vector control tools for reducing the malaria burden in Tanzania: a qualitative exploration of perceptions of mosquitoes and methods for their control among the residents of Dar es Salaam. Malar J. 2017;16:410.","journal-title":"Malar J"},{"key":"5320_CR23","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s12936-015-0770-8","volume":"14","author":"D Iskander","year":"2015","unstructured":"Iskander D. Re-imaging malaria in the Philippines: how photovoice can help to re-imagine malaria. Malar J. 2015;14:257.","journal-title":"Malar J"},{"key":"5320_CR24","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1177\/109019819702400309","volume":"24","author":"C Wang","year":"1997","unstructured":"Wang C, Burris MA. Photovoice: concept, methodology, and use for participatory needs assessment. Health Educ Behav. 1997;24:369\u201387.","journal-title":"Health Educ Behav"},{"key":"5320_CR25","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1089\/jwh.1999.8.185","volume":"8","author":"CC Wang","year":"1999","unstructured":"Wang CC. Photovoice: a participatory action research strategy applied to women\u2019s health. J Womens Health. 1999;8:185\u201392.","journal-title":"J Womens Health"},{"key":"5320_CR26","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s13063-023-07098-2","volume":"24","author":"C Chaccour","year":"2023","unstructured":"Chaccour C, Casellas A, Hammann F, Ruiz-Castillo P, Nicolas P, Monta\u00f1a J, et al. BOHEMIA: Broad One Health Endectocide-based Malaria Intervention in Africa-a phase III cluster-randomized, open-label, clinical trial to study the safety and efficacy of ivermectin mass drug administration to reduce malaria transmission in two African settings. Trials. 2023;24:128.","journal-title":"Trials"},{"key":"5320_CR27","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/s12936-018-2489-9","volume":"17","author":"PM Macharia","year":"2018","unstructured":"Macharia PM, Giorgi E, Noor AM, Waqo E, Kiptui R, Okiro EA, et al. Spatio-temporal analysis of Plasmodium falciparum prevalence to understand the past and chart the future of malaria control in Kenya. Malar J. 2018;17:340.","journal-title":"Malar J"},{"key":"5320_CR28","unstructured":"Chaccour C, Maia M, Kariuki M, Ruiz-Castillo P et al. Ivermectin to reduce malaria transmission in Sub-Saharan Africa\u2014The BOHEMIA cluster randomized trial in Kenya. Abstract presented at the American Society of Tropical Medicine and Hygiene conference, New Orleans, LA, USA, 13\u201317 November 2024."},{"key":"5320_CR29","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1086\/653208","volume":"202","author":"C Chaccour","year":"2010","unstructured":"Chaccour C, Lines J, Whitty CJ. Effect of ivermectin on Anopheles gambiae mosquitoes fed on humans: the potential of oral insecticides in malaria control. J Infect Dis. 2010;202:113\u20136.","journal-title":"J Infect Dis"},{"key":"5320_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2024.107236","volume":"148","author":"Y Kamau","year":"2024","unstructured":"Kamau Y, Tuwei M, Wanjiku C, Ominde K, Ngama M, Karisa J, et al. Mosquitocidal efficacy and pharmacokinetics of single-dose ivermectin versus three-day dose regimen for malaria vector control compared with albendazole and no treatment: an open-label randomized controlled trial. Int J Infect Dis. 2024;148: 107236.","journal-title":"Int J Infect Dis"},{"key":"5320_CR31","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/s13071-018-2881-x","volume":"11","author":"CR Titaley","year":"2018","unstructured":"Titaley CR, Damayanti R, Soeharno N, Mu\u2019sayaroh A, Bradley M, Lynam T, et al. Assessing knowledge about lymphatic filariasis and the implementation of mass drug administration amongst drug deliverers in three districts\/cities of Indonesia. Parasit Vectors. 2018;11:315.","journal-title":"Parasit Vectors"},{"key":"5320_CR32","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/tmi.13195","volume":"24","author":"JL Browne","year":"2019","unstructured":"Browne JL, Rees CO, van Delden JJM, Agyepong I, Grobbee DE, Edwain A, et al. The willingness to participate in biomedical research involving human beings in low- and middle-income countries: a systematic review. Trop Med Int Health. 2019;24:264\u201379.","journal-title":"Trop Med Int Health"},{"key":"5320_CR33","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12910-023-00920-1","volume":"24","author":"N Busisiwe","year":"2023","unstructured":"Busisiwe N, Seeley J, Strode A, Parker M. Beyond translations, perspectives for researchers to consider to enhance comprehension during consent processes for health research in sub-Saharan Africa: a scoping review. BMC Med Ethics. 2023;24:43.","journal-title":"BMC Med Ethics"},{"key":"5320_CR34","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12910-024-01033-z","volume":"25","author":"MK Iseselo","year":"2024","unstructured":"Iseselo MK, Tarimo EAM. Comprehension of informed consent and voluntary participation in registration cohorts for phase IIb HIV vaccine trial in Dar Es Salaam, Tanzania: a qualitative descriptive study. BMC Med Ethics. 2024;25:29.","journal-title":"BMC Med Ethics"},{"key":"5320_CR35","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.3390\/pathogens10121588","volume":"10","author":"AC Erber","year":"2021","unstructured":"Erber AC, Ariyo E, Olliaro P, Nicolas P, Chaccour C, Colebunders R. Treatment of pregnant women with ivermectin during mass drug distribution: time to investigate its safety and potential benefits. Pathogens. 2021;10:1588.","journal-title":"Pathogens"},{"key":"5320_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0126671","volume":"10","author":"DM Kamuya","year":"2015","unstructured":"Kamuya DM, Theobald SJ, Marsh V, Parker M, Geissler WP, Molyneux SC. \u201cThe one who chases you away does not tell you go\u201d: silent refusals and complex power relations in research consent processes in Coastal Kenya. PLoS ONE. 2015;10: e0126671.","journal-title":"PLoS ONE"},{"key":"5320_CR37","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2017-000320","volume":"2","author":"DM Kamuya","year":"2017","unstructured":"Kamuya DM, Molyneux CS, Theobald S. Gendered negotiations for research participation in community-based studies: implications for health research policy and practice. BMJ Glob Health. 2017;2: e000320.","journal-title":"BMJ Glob Health"},{"key":"5320_CR38","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1017\/S0021932002001098","volume":"34","author":"CS Molyneux","year":"2002","unstructured":"Molyneux CS, Murira G, Masha J, Snow RW. Intra-household relations and treatment decision-making for childhood illness: a Kenyan case study. J Biosoc Sci. 2002;34:109\u201331.","journal-title":"J Biosoc Sci"},{"key":"5320_CR39","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.actatropica.2010.06.001","volume":"116","author":"KC Kobylinski","year":"2010","unstructured":"Kobylinski KC, Deus KM, Butters MP, Hongyu T, Gray M, da Silva IM, et al. The effect of oral anthelmintics on the survivorship and re-feeding frequency of anthropophilic mosquito disease vectors. Acta Trop. 2010;116:119\u201326.","journal-title":"Acta Trop"},{"key":"5320_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002447","volume":"7","author":"A Krentel","year":"2013","unstructured":"Krentel A, Fischer PU, Weil GJ. A review of factors that influence individual compliance with mass drug administration for elimination of lymphatic filariasis. PLoS Negl Trop Dis. 2013;7: e2447.","journal-title":"PLoS Negl Trop Dis"},{"key":"5320_CR41","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12936-017-1803-2","volume":"16","author":"C Chaccour","year":"2017","unstructured":"Chaccour C, Rabinovich NR. Ivermectin to reduce malaria transmission III. Considerations regarding regulatory and policy pathways. Malar J. 2017;16:162.","journal-title":"Malar J"},{"key":"5320_CR42","doi-asserted-by":"publisher","first-page":"142","DOI":"10.4269\/ajtmh.2003.68.142","volume":"68","author":"JA Alaii","year":"2003","unstructured":"Alaii JA, van den Borne HW, Kachur SP, Mwenesi H, Vulule JM, Hawley WA, et al. Perceptions of bed nets and malaria prevention before and after a randomized controlled trial of permethrin-treated bed nets in western Kenya. Am J Trop Med Hyg. 2003;68:142\u20138.","journal-title":"Am J Trop Med Hyg"},{"key":"5320_CR43","first-page":"20240609","volume":"291","author":"CC Hayes","year":"2024","unstructured":"Hayes CC, Schal C. Review on the impacts of indoor vector control on domiciliary pests: good intentions challenged by harsh realities. Proc Biol Sci. 2024;291:20240609.","journal-title":"Proc Biol Sci"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05320-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-025-05320-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05320-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T13:24:31Z","timestamp":1741785871000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-025-05320-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,12]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5320"],"URL":"https:\/\/doi.org\/10.1186\/s12936-025-05320-x","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,12]]},"assertion":[{"value":"28 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants were explained the purpose of the study by the social science research assistants and gave written informed consent before being included. The study was approved by the WHO Research Ethics Review Committee (ERC 0003264) the Oxford Tropical Research Ethics Committee (OxTREC Ref 511-30), and the KEMRI Scientific and Ethics Review Unit (KEMRI\/SERU\/CGMR-C\/251\/4464). Approval was also provided by the Kwale County Health management Team.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"79"}}